Free Trial
OTCMKTS:LTUS

Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis

Lotus Pharmaceuticals logo
$0.0058 0.00 (-6.45%)
As of 05/28/2025 11:42 AM Eastern

About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)

Key Stats

Today's Range
$0.0058
$0.0062
50-Day Range
$0.0044
$0.0078
52-Week Range
$0.0006
$0.0079
Volume
70,000 shs
Average Volume
56,267 shs
Market Capitalization
$15.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.

Receive LTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

LTUS Stock News Headlines

Lotus Pharmaceuticals Inc Price / Book
While others chase AI stocks, smart traders do this
Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...
See More Headlines

LTUS Stock Analysis - Frequently Asked Questions

Lotus Pharmaceuticals' stock was trading at $0.0060 on January 1st, 2025. Since then, LTUS stock has decreased by 3.3% and is now trading at $0.0058.
View the best growth stocks for 2025 here
.

Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lotus Pharmaceuticals investors own include Vodafone Group Public (VOD), TILT (TLLTF), SolarWinds (SWI), Spectra Energy Partners (SEP), NextEra Energy (NEE), Energy Transfer (ET) and Ameriwest Lithium (AWLID).

Company Calendar

Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:LTUS
CIK
N/A
Employees
230
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,644,516,000
Free Float
N/A
Market Cap
$15.34 million
Optionable
Not Optionable
Beta
-2.57
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (OTCMKTS:LTUS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners